AltheaDx (IDGX) Receives New Coverage from Analysts at Laidlaw

Laidlaw initiated coverage on shares of AltheaDx (NASDAQ:IDGX) in a research report report published on Thursday, The Fly reports. The brokerage issued a buy rating on the stock.

COPYRIGHT VIOLATION NOTICE: This news story was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The legal version of this news story can be viewed at

About AltheaDx

AltheaDx, Inc is a United States-based commercial-stage molecular diagnostics company. The Company is specialized in the field of pharmacogenetics. The Company focuses on enabling physicians, managed care organizations, pharmaceutical companies and other healthcare entities to make personalized therapeutic decisions for patients.

The Fly

Receive News & Ratings for AltheaDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AltheaDx and related companies with's FREE daily email newsletter.

Leave a Reply